BR112022014586A2 - Colágeno dietário não derivado de animais - Google Patents

Colágeno dietário não derivado de animais

Info

Publication number
BR112022014586A2
BR112022014586A2 BR112022014586A BR112022014586A BR112022014586A2 BR 112022014586 A2 BR112022014586 A2 BR 112022014586A2 BR 112022014586 A BR112022014586 A BR 112022014586A BR 112022014586 A BR112022014586 A BR 112022014586A BR 112022014586 A2 BR112022014586 A2 BR 112022014586A2
Authority
BR
Brazil
Prior art keywords
collagen
derived
dietary
animals
naturally occurring
Prior art date
Application number
BR112022014586A
Other languages
English (en)
Inventor
Ouzounov Nikolay
R Mellin Jeffrey
Co Julia
Original Assignee
Geltor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geltor Inc filed Critical Geltor Inc
Publication of BR112022014586A2 publication Critical patent/BR112022014586A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A23L2/66—Proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/24—Organic nitrogen compounds
    • A21D2/26—Proteins
    • A21D2/261—Animal proteins
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/24—Organic nitrogen compounds
    • A21D2/26—Proteins
    • A21D2/264—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/385—Concentrates of non-alcoholic beverages
    • A23L2/39—Dry compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/002—Preparations for repairing the hair, e.g. hair cure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/008—Preparations for oily hair
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D13/00—Finished or partly finished bakery products
    • A21D13/80—Pastry not otherwise provided for elsewhere, e.g. cakes, biscuits or cookies
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A23G3/44—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/195—Proteins from microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Genetics & Genomics (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Rheumatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)

Abstract

COLÁGENO DIETÁRIO NÃO DERIVADO DE ANIMAIS. A presente invenção refere-se a polipeptídeos de ocorrência não natural compreendendo uma sequência de um fragmento de um colágeno e células recombinantes contendo sequências de ácido nucleico heterólogas codificando os polipeptídeos de ocorrência não natural. Além disso, são fornecidos aqui métodos não derivados de animais de gerar e purificar tais polipeptídeos de ocorrência não natural usando micro-organismos, preferencialmente a partir de células bacterianas.
BR112022014586A 2020-01-24 2021-01-22 Colágeno dietário não derivado de animais BR112022014586A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062965700P 2020-01-24 2020-01-24
US202063117243P 2020-11-23 2020-11-23
PCT/US2021/014714 WO2021150959A1 (en) 2020-01-24 2021-01-22 Animal-free dietary collagen

Publications (1)

Publication Number Publication Date
BR112022014586A2 true BR112022014586A2 (pt) 2022-09-13

Family

ID=76991717

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022014586A BR112022014586A2 (pt) 2020-01-24 2021-01-22 Colágeno dietário não derivado de animais

Country Status (11)

Country Link
US (3) US11174300B2 (pt)
EP (1) EP4093761A4 (pt)
JP (1) JP2023513435A (pt)
CN (1) CN115298212A (pt)
AU (1) AU2021211721A1 (pt)
BR (1) BR112022014586A2 (pt)
CA (1) CA3168802A1 (pt)
GB (1) GB2610313A (pt)
MX (1) MX2022009036A (pt)
TW (1) TW202134267A (pt)
WO (1) WO2021150959A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2022009036A (es) 2020-01-24 2022-11-14 Geltor Inc Colageno dietetico no de animales.
WO2023009656A1 (en) * 2021-07-28 2023-02-02 Geltor, Inc. Pharmaceutical compositions and methods for treating connective tissue conditions with collagen polypeptides
KR20240039023A (ko) * 2021-07-28 2024-03-26 젤터, 인코포레이티드 동물 유래 물질이 없는 화장용 콜라겐

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6653450B1 (en) 1993-01-28 2003-11-25 Cohesion Technologies, Inc. Mutated recombinant collagens
WO1997038710A1 (en) 1996-04-12 1997-10-23 Fibrogen, Inc. Synthesis of human procollagens and collagens in recombinant dna systems
FR2757874B1 (fr) 1996-12-17 2003-04-25 Biocem Collagenes recombinants et proteines derivees produits par les plantes, leurs procedes d'obtention et leurs utilisations
AUPO811797A0 (en) 1997-07-18 1997-08-14 University Of Sydney, The Tropoelastin derivatives
US6428978B1 (en) 1998-05-08 2002-08-06 Cohesion Technologies, Inc. Methods for the production of gelatin and full-length triple helical collagen in recombinant cells
US6992172B1 (en) 1999-11-12 2006-01-31 Fibrogen, Inc. Recombinant gelatins
US6682760B2 (en) 2000-04-18 2004-01-27 Colbar R&D Ltd. Cross-linked collagen matrices and methods for their preparation
TW499433B (en) * 2000-12-27 2002-08-21 Ind Tech Res Inst Novel human Α1-chain collagen
CN1500876A (zh) * 2002-11-14 2004-06-02 �й������ž�����ҽѧ��ѧԺ����ҽ 一种编码鸡ⅱ型胶原蛋白的全长多核苷酸序列及其用途
EP1584630A1 (en) 2004-04-08 2005-10-12 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Method for preparing a modified protein outside a host cell
US7932353B2 (en) 2005-02-23 2011-04-26 Fujifilm Manufacturing Europe B.V. Non-glycosylated recombinant collagen-like polypeptides
WO2006133107A2 (en) 2005-06-03 2006-12-14 The Texas A & M University System Specific binding sites in collagen for integrins and use thereof
WO2007044945A2 (en) 2005-10-13 2007-04-19 Gu, Jennifer, L. Mineral collagen chelates and methods of making and using same
US7279329B2 (en) 2005-10-17 2007-10-09 Industrial Technology Research Institute Expression system for producing collagen
US8841255B2 (en) 2005-12-20 2014-09-23 Duke University Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides
DE602006011791D1 (de) 2006-03-13 2010-03-04 Becker & Co Naturinwerk Kollagenpulver und auf kollagen basierende thermoplastische zusammensetzung zur herstellung von formkörpern
EP2054442A2 (en) * 2006-06-14 2009-05-06 Cell-Matrix, Inc. Denatured collagen peptides and uses thereof
EP2117620A4 (en) 2006-09-29 2010-12-01 Martin Kean Chong Ng PROTOELASTINE BIOMATERIALS FROM TROOELASTINE
EP2220246B1 (en) 2007-10-26 2015-05-20 Collplant Ltd. Methods of processing recombinant procollagen
US7910134B2 (en) 2007-10-29 2011-03-22 Ayman Boutros Alloplastic injectable dermal filler and methods of use thereof
US8507652B2 (en) 2008-02-08 2013-08-13 Luis Eduardo da Cruz Pharmaceutical composition, dressing and method for treating skin lesion, intermediate composition and process for preparing said dressing, and use of cerium salt associated with a collagen matrix
GB0820784D0 (en) * 2008-11-13 2008-12-24 Nordic Bioscience As Assessment of protein degradation by measurement of isomerised neo-epitope containing fragments
US9382310B2 (en) 2009-02-06 2016-07-05 Rutgers, The State University Of New Jersey Expression of triple-helical collagen-like products in E. coli
EP3173792B1 (en) * 2009-03-30 2019-06-12 Nordic Bioscience A/S Crp neo-epitope fibrosis assay
EP2454367B1 (en) 2009-07-17 2013-10-16 The Texas A&M University System Designer collagens and uses thereof
US9402857B2 (en) 2009-07-23 2016-08-02 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and astaxanthin
DE102010060564A1 (de) 2010-11-15 2012-05-16 Gelita Ag Verwendung von Kollagenhydrolysat zur Verbesserung der Gesundheit der menschlichen Haut, Haare und/oder Nägel
WO2012149136A1 (en) 2011-04-26 2012-11-01 The Board Of Trustees Of The Leland Stanford Junior University Production and delivery of a stable collagen
AU2012289916B2 (en) 2011-08-03 2017-08-03 Phoenix Tissue Repair, Inc. Collagen 7 and related methods
TWI592421B (zh) 2011-08-09 2017-07-21 双美生物科技股份有限公司 一種三重交聯之膠原蛋白、製造方法及其用途
EP2758032B1 (en) 2011-09-21 2021-10-27 Shiseido Americas Corporation Compositions and methods for treating conditions of compromised skin barrier function
JP5992529B2 (ja) * 2012-09-26 2016-09-14 富士フイルム株式会社 ポリペプチド、足場組成物、軟骨組織修復用組成物、軟骨細胞培養用組成物及びグリコサミノグリカン産生促進用組成物
WO2014106830A1 (en) 2013-01-07 2014-07-10 Ramot At Tel-Aviv University Ltd. Jellyfish-derived polymer
BR112015023447A2 (pt) 2013-03-21 2017-12-05 Commw Scient Ind Res Org purificação de proteínas helicoidais triplas
WO2015031950A1 (en) 2013-09-09 2015-03-12 Commonwealth Scientific And Industrial Research Organisation Modified bacterial collagen-like proteins
AU2014324900A1 (en) 2013-09-25 2016-05-19 Axcella Health Inc. Compositions and formulations for prevention and reduction of tumorigenesis, cancer cell proliferation and invasion, and methods of production and use thereof in cancer treatment
US10232008B1 (en) 2015-10-05 2019-03-19 Michael P. Moran Multi-purpose nutritional supplement composition
AU2016354456B2 (en) 2015-11-09 2022-02-17 Shiseido Company, Ltd. Compositions and methods for application over skin
GB201601136D0 (en) 2016-01-21 2016-03-09 Mörgelin Matthias And Abdillahi Suado M Novel polypeptides and medical uses thereof
US10226550B2 (en) 2016-03-11 2019-03-12 Brigham Young University Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
US10669327B2 (en) 2016-03-16 2020-06-02 Phoenix Tissue Repair, Inc. Methods of purifying collagen 7
CN106554410B (zh) 2016-06-02 2019-11-26 陕西东大生化科技有限责任公司 一种重组人源胶原蛋白及其编码基因和制备方法
CN106119322B (zh) 2016-07-22 2019-10-15 江苏江山聚源生物技术有限公司 一种提高重组人源胶原蛋白生产水平的发酵工艺
KR20190042006A (ko) 2016-08-30 2019-04-23 겔리타 아게 지구력 성능을 향상시키고 지질 이화작용을 자극하기 위한 콜라겐 가수분해물의 용도
FR3058142B1 (fr) 2016-10-28 2023-11-24 Gelatines Weishardt Composition de peptides de collagene de peau de poisson et son utilisation a titre de medicament
CL2016003387A1 (es) 2016-12-29 2018-10-12 Univ De Santiago De Chile Usach Recubrimiento y/o película comestible para la conservación de productos cárneos
WO2019023555A1 (en) 2017-07-28 2019-01-31 Evelo Biosciences, Inc. POLYMER COMPOSITIONS
WO2019046943A1 (en) 2017-09-06 2019-03-14 University Of Ottawa PROTEINS OF THE COLLAGEN TYPE
US11180541B2 (en) * 2017-09-28 2021-11-23 Geltor, Inc. Recombinant collagen and elastin molecules and uses thereof
GB201717134D0 (en) 2017-10-18 2017-12-06 Univ Swansea Monomeric collagen
IL274761B1 (en) * 2017-11-22 2024-03-01 Geltor Inc Methods and systems for collagen engineering
DE102018104590A1 (de) 2018-02-28 2019-08-29 Gelita Ag Nutrazeutische oder pharmazeutische Zusammensetzung
JP7317964B2 (ja) * 2019-04-01 2023-07-31 ジェルター， インコーポレイテッド 組換えコラーゲンの局所製剤
US11666639B2 (en) 2019-06-03 2023-06-06 Societe Des Produits Nestle S.A. Recovery dietary supplement
MX2022009036A (es) 2020-01-24 2022-11-14 Geltor Inc Colageno dietetico no de animales.

Also Published As

Publication number Publication date
WO2021150959A1 (en) 2021-07-29
US20210277075A1 (en) 2021-09-09
EP4093761A4 (en) 2024-04-17
GB202212264D0 (en) 2022-10-05
EP4093761A1 (en) 2022-11-30
MX2022009036A (es) 2022-11-14
JP2023513435A (ja) 2023-03-31
US11332505B2 (en) 2022-05-17
TW202134267A (zh) 2021-09-16
CA3168802A1 (en) 2021-07-29
US11174300B2 (en) 2021-11-16
CN115298212A (zh) 2022-11-04
US20220017581A1 (en) 2022-01-20
AU2021211721A1 (en) 2022-08-18
GB2610313A (en) 2023-03-01
US20220332775A1 (en) 2022-10-20

Similar Documents

Publication Publication Date Title
BR112022014586A2 (pt) Colágeno dietário não derivado de animais
IL86480A (en) Recombinant dna coding for human proapolipoprotein a-1,expression vectors containing it and cells transformed by said expression vector
MX2014011600A (es) Proteínas nutritivas, fragmentos y métodos.
BRPI0919932A8 (pt) Pirrolina-carbóxi-lisina gerada biossinteticamente, bem como processo para preparar método para derivatizar uma proteína
AR070058A1 (es) Enzima bacteriana asociada con la sintesis de ecuol
BRPI0411475A (pt) adições de código genético de aminoácido reativo não natural
IN2012DN02981A (pt)
EP2589658A4 (en) PARTICLE POLYPEPTIDE OF THE REIC / DKK-3 PROTEIN
BR112022006233A2 (pt) Composições e métodos para síntese in vivo de polipeptídeos não naturais
CO2017011431A2 (es) Proteínas de fusión de receptor de factor de crecimiento epidermal variante iii - mesotelina
MX2020012332A (es) Casetes de expresion de alfa-glucosidasa de acido optimizado con codon y metodos de uso del mismo.
BR112013031686B8 (pt) proteína de fusão, sequência de ácido nucleico isolada,construto de ácido nucleico, vetor de expressão recombinante, célula hospedeira procariótica ou fúngica recombinante, método para a produção da proteína de fusão,composição, uso da referida composição e composição de ração animal
BR112022006842A2 (pt) Construtos de igf2 variante
MY186776A (en) Method for producing lipid
BR112017009515A8 (pt) Fitase, método para obter a mesma e uso do mesmo
MX2022003002A (es) Secuencia de extension n-terminal para la expresion de peptidos terapeuticos recombinantes.
MX2022013737A (es) Nueva proteina y usos terapeuticos y cosmeticos de la misma.
MX2020013509A (es) Composiciones y métodos para la modificación postraduccional in vivo.
RU2004139054A (ru) Модифицированные фитазы
MX2016002556A (es) Métodos y composiciones para el tratamiento de patologías del tejido de cartílago y disco.
MX2020008558A (es) Peptido del antigeno de cancer.
AR118125A2 (es) Péptido, composición, método para identificar células t específicas de péptido fviii, proteína de fusión y método para preparar un péptido fviii
AR114927A1 (es) Neoantígenos y usos de los mismos
AR104231A1 (es) Proteínas de fusión inmunogénicas para el tratamiento del cáncer
AR037054A1 (es) Composiciones y metodos de diagnostico y terapia de cancer de pulmon